<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31043534</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>14</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Polyamine Depletion Inhibits Bunyavirus Infection via Generation of Noninfectious Interfering Virions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e00530-19</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00530-19</ELocationID><Abstract><AbstractText>Several host and viral processes contribute to forming infectious virions. Polyamines are small host molecules that play diverse roles in viral replication. We previously demonstrated that polyamines are crucial for RNA viruses; however, the mechanisms by which polyamines function remain unknown. Here, we investigated the role of polyamines in the replication of the bunyaviruses Rift Valley fever virus (vaccine strain MP-12) and La Crosse virus (LACV). We found that polyamine depletion did not impact viral RNA or protein accumulation, despite significant decreases in titer. Viral particles demonstrated no change in morphology, size, or density. Thus, polyamine depletion promotes the formation of noninfectious particles. These particles interfere with virus replication and stimulate innate immune responses. We extended this phenotype to Zika virus; however, coxsackievirus did not similarly produce noninfectious particles. In sum, polyamine depletion results in the accumulation of noninfectious particles that interfere with replication and stimulate immune signaling, with important implications for targeting polyamines therapeutically, as well as for vaccine strategies.<b>IMPORTANCE</b> Bunyaviruses are emerging viral pathogens that cause encephalitis, hemorrhagic fevers, and meningitis. We have uncovered that diverse bunyaviruses require polyamines for productive infection. Polyamines are small, positively charged host-derived molecules that play diverse roles in human cells and in infection. In polyamine-depleted cells, bunyaviruses produce an overabundance of noninfectious particles that are indistinguishable from infectious particles. However, these particles interfere with productive infection and stimulate antiviral signaling pathways. We further find that additional enveloped viruses are similarly sensitive to polyamine depletion but that a nonenveloped enterovirus is not. We posit that polyamines are required to maintain bunyavirus infectivity and that polyamine depletion results in the accumulation of interfering noninfectious particles that limit infectivity. These results highlight a novel means by which bunyaviruses use polyamines for replication and suggest promising means to target host polyamines to reduce virus replication.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 American Society for Microbiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mastrodomenico</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esin</LastName><ForeName>Jeremy J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Marion L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tate</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Grant M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandler</LastName><ForeName>Zachary J</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rademacher</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Core Imaging Facility, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kicmal</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dial</LastName><ForeName>Courtney N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mounce</LastName><ForeName>Bryan C</ForeName><Initials>BC</Initials><Identifier Source="ORCID">0000-0003-1710-5362</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA bmounce@luc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015317">Biogenic Polyamines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015317" MajorTopicYN="N">Biogenic Polyamines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002044" MajorTopicYN="N">Bunyaviridae Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003673" MajorTopicYN="N">Defective Viruses</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002141" MajorTopicYN="N">Encephalitis Virus, California</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012296" MajorTopicYN="N">Rift Valley fever virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bunyaviruses</Keyword><Keyword MajorTopicYN="N">noninfectious particles</Keyword><Keyword MajorTopicYN="N">polyamines</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31043534</ArticleId><ArticleId IdType="pmc">PMC6600196</ArticleId><ArticleId IdType="doi">10.1128/JVI.00530-19</ArticleId><ArticleId IdType="pii">JVI.00530-19</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Linthicum KJ, Britch SC, Anyamba A. 2016. Rift Valley fever: an emerging mosquito-borne disease. Annu Rev Entomol 61:395&#x2013;415. doi:10.1146/annurev-ento-010715-023819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-ento-010715-023819</ArticleId><ArticleId IdType="pubmed">26982443</ArticleId></ArticleIdList></Reference><Reference><Citation>McJunkin JE, Khan RR, Tsai TF. 1998. California-La Crosse encephalitis. Infect Dis Clin North Am 12:83&#x2013;93. doi:10.1016/S0891-5520(05)70410-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5520(05)70410-4</ArticleId><ArticleId IdType="pubmed">9494831</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero JR, Newland JG. 2003. Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis 14:72&#x2013;82. doi:10.1053/spid.2003.127223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/spid.2003.127223</ArticleId><ArticleId IdType="pubmed">12881794</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney M-C, Lavenir R, Pardigon N, Reynes J-M, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel M-P, Br&#xe9;hin A-C, Cubito N, Despr&#xe8;s P, Kunst F, Rey FA, Zeller H, Brisse S. 2006. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 3:e263. doi:10.1371/journal.pmed.0030263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0030263</ArticleId><ArticleId IdType="pmc">PMC1463904</ArticleId><ArticleId IdType="pubmed">16700631</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikan N, Smith DR. 2016. Zika virus: history of a newly emerging arbovirus. Lancet Infect Dis 16:e119&#x2013;e126. doi:10.1016/S1473-3099(16)30010-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)30010-X</ArticleId><ArticleId IdType="pubmed">27282424</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutailler S, Roche B, Thiberge J-M, Caro V, Rougeon F, Failloux A-B. 2011. Host alternation is necessary to maintain the genome stability of Rift Valley fever virus. PLoS Negl Trop Dis 5:e1156. doi:10.1371/journal.pntd.0001156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001156</ArticleId><ArticleId IdType="pmc">PMC3101185</ArticleId><ArticleId IdType="pubmed">21629727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowen AC, Boyd A, Fazakerley JK, Elliott RM. 2005. Attenuation of bunyavirus replication by rearrangement of viral coding and noncoding sequences. J Virol 79:6940&#x2013;6946. doi:10.1128/JVI.79.11.6940-6946.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.11.6940-6946.2005</ArticleId><ArticleId IdType="pmc">PMC1112153</ArticleId><ArticleId IdType="pubmed">15890933</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfson KJ, Avena LE, Beadles MW, Staples H, Nunneley JW, Ticer A, Dick EJ, Owston MA, Reed C, Patterson JL, Carrion R, Griffiths A. 2015. Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques. J Virol 89:6773&#x2013;6781. doi:10.1128/JVI.00649-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00649-15</ArticleId><ArticleId IdType="pmc">PMC4468478</ArticleId><ArticleId IdType="pubmed">25903348</ArticleId></ArticleIdList></Reference><Reference><Citation>Mingozzi F, Anguela XM, Pavani G, Chen Y, Davidson RJ, Hui DJ, Yazicioglu M, Elkouby L, Hinderer CJ, Faella A, Howard C, Tai A, Podsakoff GM, Zhou S, Basner-Tschakarjan E, Wright JF, High KA. 2013. Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci Transl Med 5:194ra92. doi:10.1126/scitranslmed.3005795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3005795</ArticleId><ArticleId IdType="pmc">PMC4095828</ArticleId><ArticleId IdType="pubmed">23863832</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient R, Hourioux C, Roingeard P. 2009. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell Microbiol 11:1561&#x2013;1570. doi:10.1111/j.1462-5822.2009.01363.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2009.01363.x</ArticleId><ArticleId IdType="pmc">PMC2909707</ArticleId><ArticleId IdType="pubmed">19673892</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezelj VV, Levi LI, Vignuzzi M. 2018. The defective component of viral populations. Curr Opin Virol 33:74&#x2013;80. doi:10.1016/j.coviro.2018.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2018.07.014</ArticleId><ArticleId IdType="pubmed">30099321</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Sun Y, Li Y, Ruthel G, Weiss SR, Raj A, Beiting D, L&#xf3;pez CB. 2017. Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence. Nat Commun 8:799. doi:10.1038/s41467-017-00909-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00909-6</ArticleId><ArticleId IdType="pmc">PMC5630589</ArticleId><ArticleId IdType="pubmed">28986577</ArticleId></ArticleIdList></Reference><Reference><Citation>Poirier EZ, Goic B, Tom&#xe9;-Poderti L, Frangeul L, Boussier J, Gausson V, Blanc H, Vallet T, Loyd H, Levi LI, Lanciano S, Baron C, Merkling SH, Lambrechts L, Mirouze M, Carpenter S, Vignuzzi M, Saleh M-C. 2018. Dicer-2-dependent generation of viral DNA from defective genomes of RNA viruses modulates antiviral immunity in insects. Cell Host Microbe 23:353&#x2013;365. doi:10.1016/j.chom.2018.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.02.001</ArticleId><ArticleId IdType="pmc">PMC5857290</ArticleId><ArticleId IdType="pubmed">29503180</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerner EW, Meyskens FL. 2004. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4:781&#x2013;792. doi:10.1038/nrc1454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc1454</ArticleId><ArticleId IdType="pubmed">15510159</ArticleId></ArticleIdList></Reference><Reference><Citation>Frugier M, Florentz C, Hosseini MW, Lehn JM, Gieg&#xe9; R. 1994. Synthetic polyamines stimulate in vitro transcription by T7 RNA polymerase. Nucleic Acids Res 22:2784&#x2013;2790. doi:10.1093/nar/22.14.2784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/22.14.2784</ArticleId><ArticleId IdType="pmc">PMC308248</ArticleId><ArticleId IdType="pubmed">8052534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Mandal A, Johansson HE, Orjalo AV, Park MH. 2013. Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells. Proc Natl Acad Sci U S A 110:2169&#x2013;2174. doi:10.1073/pnas.1219002110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219002110</ArticleId><ArticleId IdType="pmc">PMC3568356</ArticleId><ArticleId IdType="pubmed">23345430</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabian CJ, Kimler BF, Brady DA, Mayo MS, Chang CHJ, Ferraro JA, Zalles CM, Stanton AL, Masood S, Grizzle WE, Boyd NF, Arneson DW, Johnson KA. 2002. A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Clin Cancer Res 8:3105&#x2013;3117.</Citation><ArticleIdList><ArticleId IdType="pubmed">12374678</ArticleId></ArticleIdList></Reference><Reference><Citation>Simoneau AR, Gerner EW, Nagle R, Ziogas A, Fujikawa-Brooks S, Yerushalmi H, Ahlering TE, Lieberman R, McLaren CE, Anton-Culver H, Meyskens FL. 2008. The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial. Cancer Epidemiol Biomark Prev 17:292&#x2013;299. doi:10.1158/1055-9965.EPI-07-0658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-07-0658</ArticleId><ArticleId IdType="pmc">PMC2515594</ArticleId><ArticleId IdType="pubmed">18268112</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Poirier EZ, Passoni G, Simon-Loriere E, Cesaro T, Prot M, Stapleford KA, Moratorio G, Sakuntabhai A, Levraud J-P, Vignuzzi M. 2016. Interferon-induced spermidine-spermine acetyltransferase and polyamine depletion restrict Zika and chikungunya viruses. Cell Host Microbe 20:167&#x2013;177. doi:10.1016/j.chom.2016.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.06.011</ArticleId><ArticleId IdType="pubmed">27427208</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen ME, Filone CM, Rozelle D, Mire CE, Agans KN, Hensley L, Connor JH. 2016. Polyamines and hypusination are required for Ebolavirus gene expression and replication. mBio 7:e00882-16. doi:10.1128/mBio.00882-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00882-16</ArticleId><ArticleId IdType="pmc">PMC4981715</ArticleId><ArticleId IdType="pubmed">27460797</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen ME, Cressey TN, M&#xfc;hlberger E, Connor JH. 2018. Differential mechanisms for the involvement of polyamines and hypusinated eIF5A in Ebola virus gene expression. J Virol 92:e01260-18. doi:10.1128/JVI.01260-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01260-18</ArticleId><ArticleId IdType="pmc">PMC6158423</ArticleId><ArticleId IdType="pubmed">30045993</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Cesaro T, Moratorio G, Hooikaas PJ, Yakovleva A, Werneke SW, Smith EC, Poirier EZ, Simon-Loriere E, Prot M, Tamietti C, Vitry S, Volle R, Khou C, Frenkiel M-P, Sakuntabhai A, Delpeyroux F, Pardigon N, Flamand M, Barba-Spaeth G, Lafon M, Denison MR, Albert ML, Vignuzzi M. 2016. Inhibition of polyamine biosynthesis is a broad-spectrum strategy against RNA viruses. J Virol 90:9683&#x2013;9692. doi:10.1128/JVI.01347-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-16</ArticleId><ArticleId IdType="pmc">PMC5068521</ArticleId><ArticleId IdType="pubmed">27535047</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson W, Roizman B. 1971. Compartmentalization of spermine and spermidine in the herpes simplex virion. Proc Natl Acad Sci U S A 68:2818&#x2013;2821. doi:10.1073/pnas.68.11.2818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.68.11.2818</ArticleId><ArticleId IdType="pmc">PMC389533</ArticleId><ArticleId IdType="pubmed">5288261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanzer W, Holowczak JA. 1975. Polyamines in vaccinia virions and polypeptides released from viral cores by acid extraction. J Virol 16:1254&#x2013;1264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC355725</ArticleId><ArticleId IdType="pubmed">1185852</ArticleId></ArticleIdList></Reference><Reference><Citation>Raina A, Tuomi K, M&#xe4;ntyj&#xe4;rvi R. 1981. Roles of polyamines in the replication of animal viruses. Med Biol 59:428&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pubmed">6279979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov IP, Shin B-S, Loughran G, Tzani I, Young-Baird SK, Cao C, Atkins JF, Dever TE. 2018. Polyamine control of translation elongation regulates start site selection on antizyme inhibitor mRNA via ribosome queuing. Mol Cell 70:254&#x2013;264. doi:10.1016/j.molcel.2018.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.03.015</ArticleId><ArticleId IdType="pmc">PMC5916843</ArticleId><ArticleId IdType="pubmed">29677493</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal L, Supko JG, Berlin J, Blaszkowsky LS, Carpenter A, Heuman DM, Hilderbrand SL, Stuart KE, Cotler S, Senzer NN, Chan E, Berg CL, Clark JW, Hezel AF, Ryan DP, Zhu AX. 2013. Phase 1 study of N(1),N(11)&#x2011;diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 72:1305&#x2013;1314. doi:10.1007/s00280-013-2293-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00280-013-2293-8</ArticleId><ArticleId IdType="pubmed">24121453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff AC, Armstrong DK, Fetting JH, Carducci MK, Riley CD, Bender JF, Casero RA, Davidson NE. 2003. A phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer. Clin Cancer Res 9:5922&#x2013;5928.</Citation><ArticleIdList><ArticleId IdType="pubmed">14676116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis DS, Shirodaria PV, Fleming E, Simpson D. 1988. Morphology and development of Rift Valley fever virus in Vero cell cultures. J Med Virol 24:161&#x2013;174. doi:10.1002/jmv.1890240205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890240205</ArticleId><ArticleId IdType="pubmed">3280732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikegami T, Won S, Peters CJ, Makino S. 2006. Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 80:2933&#x2013;2940. doi:10.1128/JVI.80.6.2933-2940.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.6.2933-2940.2006</ArticleId><ArticleId IdType="pmc">PMC1395455</ArticleId><ArticleId IdType="pubmed">16501102</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, Haller O. 2001. Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs. J Virol 75:1371&#x2013;1377. doi:10.1128/JVI.75.3.1371-1377.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.3.1371-1377.2001</ArticleId><ArticleId IdType="pmc">PMC114043</ArticleId><ArticleId IdType="pubmed">11152510</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohl A, Clayton RF, Weber F, Bridgen A, Randall RE, Elliott RM. 2003. Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J Virol 77:7999&#x2013;8008. doi:10.1128/JVI.77.14.7999-8008.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.14.7999-8008.2003</ArticleId><ArticleId IdType="pmc">PMC161919</ArticleId><ArticleId IdType="pubmed">12829839</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber F, Bridgen A, Fazakerley JK, Streitenfeld H, Kessler N, Randall RE, Elliott RM. 2002. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 76:7949&#x2013;7955. doi:10.1128/JVI.76.16.7949-7955.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.16.7949-7955.2002</ArticleId><ArticleId IdType="pmc">PMC155133</ArticleId><ArticleId IdType="pubmed">12133999</ArticleId></ArticleIdList></Reference><Reference><Citation>Lednicky JA, White SK, Stephenson CJ, Cherabuddi K, Loeb JC, Moussatche N, Lednicky A, Morris JG. 2019. Keystone virus isolated from a Florida teenager with rash and subjective fever: another endemic arbovirus in the southeastern United States? Clin Infect Dis 68:143&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">29893806</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Olsen ME, Vignuzzi M, Connor JH. 2017. Polyamines and their role in virus infection. Microbiol Mol Biol Rev 81:e00029-17. doi:10.1128/MMBR.00029-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00029-17</ArticleId><ArticleId IdType="pmc">PMC5706744</ArticleId><ArticleId IdType="pubmed">28904024</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Rouzine IM, Bianco S, Acevedo A, Goldstein EF, Farkov M, Brodsky L, Andino R. 2016. RNA recombination enhances adaptability and is required for virus spread and virulence. Cell Host Microbe 19:493&#x2013;503. doi:10.1016/j.chom.2016.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.03.009</ArticleId><ArticleId IdType="pmc">PMC4840895</ArticleId><ArticleId IdType="pubmed">27078068</ArticleId></ArticleIdList></Reference><Reference><Citation>Fout GS, Medappa KC, Mapoles JE, Rueckert RR. 1984. Radiochemical determination of polyamines in poliovirus and human rhinovirus 14. J Biol Chem 259:3639&#x2013;3643.</Citation><ArticleIdList><ArticleId IdType="pubmed">6323434</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheppard SL, Burness AT, Boyle SM. 1980. Polyamines in encephalomyocarditis virus. J Virol 34:266&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC288692</ArticleId><ArticleId IdType="pubmed">6246257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent JR, Zeng P-Y, Atanasiu D, Gardner J, Fraser NW, Berger SL. 2004. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol 78:10178&#x2013;10186. doi:10.1128/JVI.78.18.10178-10186.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.18.10178-10186.2004</ArticleId><ArticleId IdType="pmc">PMC514973</ArticleId><ArticleId IdType="pubmed">15331750</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Tsan FC, Kohler S, Cirillo LA, Tarakanova VL. 2011. Dynamic association of gammaherpesvirus DNA with core histone during de novo lytic infection of primary cells. Virology 421:167&#x2013;172. doi:10.1016/j.virol.2011.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.09.024</ArticleId><ArticleId IdType="pmc">PMC3210866</ArticleId><ArticleId IdType="pubmed">22018782</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Fraser NW. 2008. Temporal association of the herpes simplex virus genome with histone proteins during a lytic infection. J Virol 82:3530&#x2013;3537. doi:10.1128/JVI.00586-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00586-07</ArticleId><ArticleId IdType="pmc">PMC2268451</ArticleId><ArticleId IdType="pubmed">18160436</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoni TB, L&#xf3;pez CB. 2018. Defective (interfering) viral genomes re-explored: impact on antiviral immunity and virus persistence. Future Virol 13:493&#x2013;503. doi:10.2217/fvl-2018-0021.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl-2018-0021</ArticleId><ArticleId IdType="pmc">PMC6136085</ArticleId><ArticleId IdType="pubmed">30245734</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteille B, Buguet A. 2012. The detection and treatment of human African trypanosomiasis. Res Rep Trop Med 3:35&#x2013;45. doi:10.2147/RRTM.S24751.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RRTM.S24751</ArticleId><ArticleId IdType="pmc">PMC6065586</ArticleId><ArticleId IdType="pubmed">30890865</ArticleId></ArticleIdList></Reference><Reference><Citation>Burri C, Brun R. 2003. Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res 90(Suppl 1):S49&#x2013;S52. doi:10.1007/s00436-002-0766-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00436-002-0766-5</ArticleId><ArticleId IdType="pubmed">12811548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramot Y, Pietil&#xe4; M, Giuliani G, Rinaldi F, Alhonen L, Paus R. 2010. Polyamines and hair: a couple in search of perfection. Exp Dermatol 19:784&#x2013;790. doi:10.1111/j.1600-0625.2010.01111.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0625.2010.01111.x</ArticleId><ArticleId IdType="pubmed">20629736</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhubala R. 1998. Thin-layer chromatographic method for assaying polyamines. Methods Mol Biol 79:131&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">9463828</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>